Tirzepatide: In a clinical trial of people with type 2 diabetes, tirzepatide caused an average weight loss of 13%15% in 72 weeks
Empower GLP-1 & Bariatric clients with this customizable Canva template
Mary here See How Our Injections Power Real Results Watch Real Patients Share Their Injection Therapy Results Schedule Your Injection Add-On at The Remedy Room Contact Form New More Treatments We Offer Explore additional therapies available at The Remedy Room that support hydration, energy, detox, recovery, and overall wellness
Pfeifer KJ, Selzer A, Mendez CE, et al
For healthcare providers, this delivery approach is designed to: Support improved absorption efficiency Enhance formulation stability and dose uniformity Reduce variability in patient experience over time Built for Scalable Weight-Management Programs BoomRx enables providers to access oral semaglutide and tirzepatide alongside other weight-management therapies, peptides, and specialty medications without navigating multiple pharmacy portals, fulfillment workflows, or state-by-state shipping requirements
Patients and healthcare providers can work together to achieve better treatment outcomes and overall health and well-being as a result of this mutual understanding